269 related articles for article (PubMed ID: 1299465)
1. Quality of life consequences of chemotherapy-induced emesis.
Lindley CM; Hirsch JD; O'Neill CV; Transau MC; Gilbert CS; Osterhaus JT
Qual Life Res; 1992 Oct; 1(5):331-40. PubMed ID: 1299465
[TBL] [Abstract][Full Text] [Related]
2. Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall.
Martin AR; Pearson JD; Cai B; Elmer M; Horgan K; Lindley C
Support Care Cancer; 2003 Aug; 11(8):522-7. PubMed ID: 12827483
[TBL] [Abstract][Full Text] [Related]
3. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.
O'Brien BJ; Rusthoven J; Rocchi A; Latreille J; Fine S; Vandenberg T; Laberge F
CMAJ; 1993 Aug; 149(3):296-302. PubMed ID: 8339175
[TBL] [Abstract][Full Text] [Related]
4. Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life.
Abunahlah N; Sancar M; Dane F; Özyavuz MK
Int J Clin Pharm; 2016 Dec; 38(6):1464-1476. PubMed ID: 27796777
[TBL] [Abstract][Full Text] [Related]
5. Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy.
Decker GM; DeMeyer ES; Kisko DL
J Support Oncol; 2006 Jan; 4(1):35-41, 52. PubMed ID: 16444851
[TBL] [Abstract][Full Text] [Related]
6. Assessing the impact of chemotherapy-induced nausea and vomiting on patients' quality of life: An Arabic version of the Functional Living Index-Emesis.
Alhammad AM; Alkhudair N; Alzaidi R; Almosabhi LS; Aljawadi MH
J Oncol Pharm Pract; 2022 Apr; 28(3):535-541. PubMed ID: 33645326
[TBL] [Abstract][Full Text] [Related]
7. The impact of chemotherapy-induced nausea and vomiting on health-related quality of life.
Ballatori E; Roila F; Ruggeri B; Betti M; Sarti S; Soru G; Cruciani G; Di Maio M; Andrea B; Deuson RR
Support Care Cancer; 2007 Feb; 15(2):179-85. PubMed ID: 16941136
[TBL] [Abstract][Full Text] [Related]
8. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
[TBL] [Abstract][Full Text] [Related]
9. Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a U.S. population.
Haiderali A; Menditto L; Good M; Teitelbaum A; Wegner J
Support Care Cancer; 2011 Jun; 19(6):843-51. PubMed ID: 20532923
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the 3-day recall period for the Functional Life Index-Emesis (FLIE).
Wan BA; Drost L; Ganesh V; Zhang L; Yee C; Tsao M; Barnes E; Pasetka M; DeAngelis C; Chow E
Ann Palliat Med; 2018 Oct; 7(4):393-403. PubMed ID: 30180722
[TBL] [Abstract][Full Text] [Related]
11. Impact of radiation-induced nausea and vomiting on quality of life.
Yee C; Drost L; Zhang L; Wan BA; Ganesh V; Tsao M; Barnes E; Pasetka M; DeAngelis C; Chow E
Support Care Cancer; 2018 Nov; 26(11):3959-3966. PubMed ID: 29808378
[TBL] [Abstract][Full Text] [Related]
12. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
[TBL] [Abstract][Full Text] [Related]
13. Symptom clusters of gastrointestinal cancer patients undergoing radiotherapy using the Functional Living Index-Emesis (FLIE) quality-of-life tool.
Poon M; Dennis K; DeAngelis C; Chung H; Stinson J; Zhang L; Bedard G; Wong E; Popovic M; Lao N; Pulenzas N; Wong S; Cheon P; Chow E
Support Care Cancer; 2015 Sep; 23(9):2589-98. PubMed ID: 25620759
[TBL] [Abstract][Full Text] [Related]
14. Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.
Chasen M; Urban L; Schnadig I; Rapoport B; Powers D; Arora S; Navari R; Schwartzberg L; Gridelli C
Support Care Cancer; 2017 Jan; 25(1):85-92. PubMed ID: 27557833
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy.
Treish I; Shord S; Valgus J; Harvey D; Nagy J; Stegal J; Lindley C
Support Care Cancer; 2003 Aug; 11(8):516-21. PubMed ID: 12836088
[TBL] [Abstract][Full Text] [Related]
16. [Development of a Japanese version of the FLIE].
Satou A; Yamazaki T; Nukariya N; Nakamachi M; Shimada K; Matsukawa M; Kurihara M
Gan To Kagaku Ryoho; 2002 Feb; 29(2):281-91. PubMed ID: 11865635
[TBL] [Abstract][Full Text] [Related]
17. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
[TBL] [Abstract][Full Text] [Related]
18. [The development of a new QOL Questionnaire on chemotherapy - induced emesis and vomiting--investigation of reliability and validity. Group for Investigation of QOL Questionnaire for Anti-Emetics Used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative study].
Ishihara Y; Nukariya N; Kobayashi K; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
Gan To Kagaku Ryoho; 1996 May; 23(6):745-55. PubMed ID: 8645026
[TBL] [Abstract][Full Text] [Related]
19. Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial.
Pérol D; Provençal J; Hardy-Bessard AC; Coeffic D; Jacquin JP; Agostini C; Bachelot T; Guastalla JP; Pivot X; Martin JP; Bajard A; Ray-Coquard I
BMC Cancer; 2012 Dec; 12():603. PubMed ID: 23244208
[TBL] [Abstract][Full Text] [Related]
20. Impact of chemotherapy-induced nausea and vomiting on quality of life in indonesian patients with gynecologic cancer.
Perwitasari DA; Atthobari J; Mustofa M; Dwiprahasto I; Hakimi M; Gelderblom H; Putter H; Nortier JW; Guchelaar HJ; Kaptein AA
Int J Gynecol Cancer; 2012 Jan; 22(1):139-45. PubMed ID: 22080888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
